Evidence map›Paper›PMID 28146062›Full record

ArticleInternational journal of molecular sciences2017

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.

Nathaniel Melling, Masoud Rashed, Cornelia Schroeder, Claudia Hube-Magg, Martina Kluth, Dagmar Lang, Ronald Simon, Christina Möller-Koop, Stefan Steurer, Guido Sauter and 14 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Gallbladder cancer integrated bioinformatics analysis of protein profile data.Gastroenterology and hepatology from bed to bench · 2019
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 1 institution in 1 country.

Nathaniel MellingInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. n.melling@uke.de.
Masoud RashedInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. masoudrashed@msn.com.
Cornelia SchroederInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. cor.schroeder@uke.de.
Claudia Hube-MaggInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. c.hube@uke.de.
Martina KluthInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. m.kluth@uke.de.
Dagmar LangInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. d.lang@uke.de.
Ronald SimonInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. r.simon@uke.de.
Christina Möller-KoopInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. c.koop@uke.de.
Stefan SteurerInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. s.steurer@uke.de.
Guido SauterInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. g.sauter@uke.de.
Frank JacobsenInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. f.jacobsen@uke.de.
Franziska BüscheckInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. f.buescheck@uke.de.
Corinna WittmerInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. c.wittmer@uke.de.
Till ClauditzInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. t.clauditz@uke.de.
Till KrechInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. t.krech@uke.de.
Maria Christina TsourlakisInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. m.tsourlakis@uke.de.
Sarah MinnerInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. s.minner@uke.de.
Hartwig HulandMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. hhuland@uke.de.
Markus GraefenMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. graefen@uke.de.
Lars BudäusMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. budaeus@uke.de.
Imke ThederanMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. i.thederan@uke.de.
Georg SalomonMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. gsalomon@uke.de.
Thorsten SchlommMartini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. t.schlomm@uke.de.
Waldemar WilczakInstitute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg D-20246, Germany. w.wilczak@uke.de.
Universität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

γ-glutamyl-hydrolase (GGH) is a ubiquitously-expressed enzyme that regulates intracellular folate metabolism for cell proliferation, DNA synthesis, and repair. Employing GGH immunohistochemistry on a tissue microarray with 12,427 prostate cancers, we found that GGH expression was negative to low in normal prostate epithelium, whereas 88.3% of our 10,562 interpretable cancers showed GGH expression. GGH staining was considered as low intensity in 49.6% and as high intensity in 38.6% of cancers. High GGH expression was linked to the TMPRSS2:ERG-fusion positive subset of cancers (

Indexed as

Biomarkers, TumorCell Proliferationgamma-Glutamyl HydrolaseGene ExpressionHumansImmunohistochemistryLymphatic MetastasisMaleMargins of ExcisionNeoplasm GradingNeoplasm StagingOncogene Proteins, FusionPrognosisProstate-Specific AntigenProstatic NeoplasmsReceptors, AndrogenBiomarkers, Tumorgamma-Glutamyl HydrolaseOncogene Proteins, FusionProstate-Specific AntigenReceptors, AndrogenTMPRSS2-ERG fusion protein, humanTranscriptional Regulator ERGdeletionERGfolic acidGGHmultivariate modelsprognostic factorsprostate cancertissue biomarkersTMA

Identifiers

PMID28146062
PMCPMC5343822
OpenAlexW2580536816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.